# TASK ORDER 06 (75N95021F00001) FOR IDIQ HHSN271201800024I WITH EUROFINS PANLABS DISCOVERY SERVICES

> **NIH NIH N01** · EUROFINS PANLABS, INC. · 2021 · $140,748

## Abstract

The Division of Therapeutics and Medical Consequences (DTMC) supports a contract-based research program (the Addiction Treatment Discovery Program) that acts to test potential medications for safety and efficacy in developing them as drugs to be used in the treatment/prevention of drug abuse.

## Key facts

- **NIH application ID:** 10505763
- **Project number:** 271201800024I-0-759502100001-1
- **Recipient organization:** EUROFINS PANLABS, INC.
- **Principal Investigator:** SARA ELLIOTT
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $140,748
- **Award type:** —
- **Project period:** 2021-09-30 → 2022-09-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10505763

## Citation

> US National Institutes of Health, RePORTER application 10505763, TASK ORDER 06 (75N95021F00001) FOR IDIQ HHSN271201800024I WITH EUROFINS PANLABS DISCOVERY SERVICES (271201800024I-0-759502100001-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10505763. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*